(Q48698480)

14 February 2018

title

Evaluation of a competitive NMDA antagonist (D-CPPene) in feline focal cerebral ischemia (English)

1 reference

https://api.crossref.org/works/10.1002/ANA.410300112

5 December 2022

1 reference

1 reference

https://api.crossref.org/works/10.1002/ANA.410300112

5 December 2022

M. Chen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1834008

5 December 2022

R. Bullock

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1834008

5 December 2022

D. I. Graham

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1834008

5 December 2022

P. Frey

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1834008

5 December 2022

D. Lowe

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1834008

5 December 2022

J. McCulloch

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1834008

5 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1834008

5 December 2022

publication date

1 July 1991

1 reference

14 February 2018

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fana.410300112

1 reference

https://api.crossref.org/works/10.1002/ANA.410300112

https://onlinelibrary.wiley.com/doi/full/10.1002/ana.410300112

5 December 2022

1 reference

https://api.crossref.org/works/10.1002/ANA.410300112

5 December 2022

1 reference

14 February 2018

volume

1 reference

14 February 2018

issue

1 reference

14 February 2018

page(s)

62-70

1 reference

14 February 2018

Free radicals in central nervous system ischemia

cites work

1 reference

https://api.crossref.org/works/10.1002%2FANA.410300112

Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: a unifying hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410300112

Dynamics of extracellular metabolites in the striatum after middle cerebral artery occlusion in the rat monitored by intracerebral microdialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410300112

Correlation between amino acid release and neuropathologic outcome in rat brain following middle cerebral artery occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410300112

Protective effect of the glutamate antagonist, MK-801 in focal cerebral ischemia in the cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410300112

Focal cerebral ischemia in the cat: pretreatment with a competitive NMDA receptor antagonist, D-CPP-ene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410300112

Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral Microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/ANA.410300112

Changes in extracellular amino acid neurotransmitters produced by focal cerebral ischemia

5 December 2022

1 reference

https://api.crossref.org/works/10.1002/ANA.410300112

Ischemic flow threshold for extracellular glutamate increase in cat cortex

5 December 2022

1 reference

https://api.crossref.org/works/10.1002/ANA.410300112

The role of excitatory amino acids and NMDA receptors in traumatic brain injury

5 December 2022

1 reference

https://api.crossref.org/works/10.1002/ANA.410300112

Focal cerebral ischaemia in the cat: treatment with the glutamate antagonist MK-801 after induction of ischaemia

5 December 2022

1 reference

https://api.crossref.org/works/10.1002/ANA.410300112

The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat

5 December 2022

1 reference

https://api.crossref.org/works/10.1002/ANA.410300112

N-methyl-D-aspartate antagonist reduces stroke size and regional glucose metabolism

5 December 2022

1 reference

https://api.crossref.org/works/10.1002/ANA.410300112

The pharmacotherapy of focal cortical ischaemia in the mouse

5 December 2022

1 reference

https://api.crossref.org/works/10.1002/ANA.410300112

The specific NMDA receptor antagonist AP-7 attenuates focal ischemic brain injury

5 December 2022

1 reference

https://api.crossref.org/works/10.1002/ANA.410300112

The competitive N-methyl-D-aspartate (NMDA) antagonist CGS 19755 attenuates the rate-decreasing effects of NMDA in rhesus monkeys without producing ketamine-like discriminative stimulus effects

5 December 2022

1 reference

https://api.crossref.org/works/10.1002/ANA.410300112

Effects of NMDA antagonists, MK-801 and CPP, upon local cerebral glucose use

5 December 2022

1 reference

https://api.crossref.org/works/10.1002/ANA.410300112

Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs

5 December 2022

1 reference

https://api.crossref.org/works/10.1002/ANA.410300112

D-CPP-ene (SDZ EAA 494), a potent and competitive N-methyl-D-aspartate (NMDA) antagonist: effect on spontaneous activity and NMDA-induced depolarizations in the rat neocortical slice preparation, compared with other CPP derivatives and MK-801.

5 December 2022

1 reference

https://api.crossref.org/works/10.1002/ANA.410300112

Quantitative assessment of early brain damage in a rat model of focal cerebral ischaemia

5 December 2022

1 reference

https://api.crossref.org/works/10.1002/ANA.410300112

Thresholds of focal cerebral ischemia in awake monkeys

5 December 2022

1 reference

https://api.crossref.org/works/10.1002/ANA.410300112

Neurobiology. Taking apart NMDA receptors

5 December 2022

1 reference

https://api.crossref.org/works/10.1002/ANA.410300112

The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor

5 December 2022

1 reference

https://api.crossref.org/works/10.1002/ANA.410300112

Potent oral anticonvulsant action of CPP and CPPene in DBA/2 mice

5 December 2022

1 reference

https://api.crossref.org/works/10.1002/ANA.410300112

Drug entry into the brain

5 December 2022

1 reference

https://api.crossref.org/works/10.1002/ANA.410300112

Anticonvulsant activity of the NMDA antagonists, D(-)4-(3-phosphonopropyl) piperazine-2-carboxylic acid (D-CPP) and D(-)(E)-4-(3-phosphonoprop-2-enyl) piperazine-2-carboxylic acid (D-CPPene) in a rodent and a primate model of reflex epilepsy

5 December 2022

1 reference

https://api.crossref.org/works/10.1002/ANA.410300112

5 December 2022

Identifiers

1 reference

14 February 2018

1 reference

14 February 2018